Michael Kauffman's Net Worth

Michael Kauffman's net worth is estimated to be at least $14,975,862.20 as of 10/04/2022. CoreStreet's estimation of Michael Kauffman's net worth is based on their sale of stock and current holding of stock.

Michael Kauffman is Director at Karyopharm Therapeutics Inc. They have executed at least 32 trades of stock as per SEC Form 4 filings. Their most recent trade was for 6,764 units of KPTI stock on 02/07/2022. Their biggest sale was on 07/02/2014 when they sold 200,000 units of Karyopharm Therapeutics Inc stock for $8,500,000.00. They typically trade 4 times per year.

Total value of insider buys:
  • $57,260.00
Total value of insider sells:
  • $14,918,602.20
Most recent insider trade:
  • Feb. 7, 2022

Michael Kauffman's Insider Trading History

Karyopharm Therapeutics IncTitleAmountPriceTypeTotal Value
Feb. 7, 2022
Director6,764$9.86Sell$66,693.04
Oct. 12, 2020
CEO7,500$14.89Sell$111,675.00
Aug. 17, 2020
CEO1,477$15.00Sell$22,155.00
July 15, 2020
CEO7,500$19.43Sell$145,725.00
July 9, 2020
CEO7,500$19.53Sell$146,475.00
June 15, 2020
CEO7,500$16.37Sell$122,775.00
June 9, 2020
CEO7,500$18.50Sell$138,750.00
April 8, 2020
CEO10,000$18.61Sell$186,100.00
Feb. 19, 2020
CEO8,817$16.48Sell$145,304.16
Jan. 9, 2020
CEO10,000$19.19Sell$191,900.00
Dec. 9, 2019
CEO10,000$17.02Sell$170,200.00
Nov. 11, 2019
CEO10,000$14.76Sell$147,600.00
Nov. 8, 2019
CEO10,000$14.63Sell$146,300.00
Nov. 1, 2019
CEO20,000$14.17Sell$283,400.00
Sept. 16, 2019
CEO10,000$12.00Sell$120,000.00
Nov. 26, 2018
CEO9,600$11.00Sell$105,600.00
Sept. 18, 2018
CEO10,000$18.26Sell$182,600.00
Aug. 20, 2018
CEO10,000$17.46Sell$174,600.00
Aug. 7, 2018
CEO12,500$18.04Sell$225,500.00
July 18, 2018
CEO10,000$18.27Sell$182,700.00
May 18, 2018
CEO10,000$19.39Sell$193,900.00
April 18, 2018
CEO10,000$14.79Sell$147,900.00
March 19, 2018
CEO10,000$15.29Sell$152,900.00
Feb. 20, 2018
CEO10,000$14.79Sell$147,900.00
Jan. 18, 2018
CEO10,000$10.09Sell$100,900.00
Dec. 18, 2017
CEO10,000$9.16Sell$91,600.00
Jan. 12, 2015
CEO50,000$33.00Sell$1,650,000.00
July 2, 2014
CEO200,000$42.50Sell$8,500,000.00
June 17, 2014
CEO20,000$41.76Sell$835,200.00
Kezar Life Sciences IncTitleAmountPriceTypeTotal Value
Jan. 3, 2022
Director5,000$16.45Sell$82,250.00
Verastem IncTitleAmountPriceTypeTotal Value
Sept. 28, 2018
Director4,000$7.49Buy$29,960.00
Sept. 17, 2014
Director3,000$9.10Buy$27,300.00